【ChiCTR2600133347】Risk Factor Identification of Dementia and Development of Hong Kong Dementia Registry
ChiCTR2600133347
尚未开始
/
/
/
2026-09-24
/
/
dementia
Risk Factor Identification of Dementia and Development of Hong Kong Dementia Registry
Risk Factor Identification of Dementia and Development of Hong Kong Dementia Registry
000000
1. To estimate the population attributable fractions of established modifiable risk factors for incident dementia in older adults in Hong Kong using locally derived prevalence and effect size estimates. 2. To identify additional sociodemographic, clinical, lifestyle, and psychosocial risk and protective factors for incident dementia and cognitive decline in the Hong Kong Chinese population. 3. To establish a territory-wide Hong Kong Dementia Registry capturing standardised clinical characteristics and longitudinal data on cognition, functional abilities, comorbidities, treatment, health and social service usage, and survival.
队列研究
其它
No randomization
None
NA
/
50000
/
2026-10-01
2041-05-31
/
Participants for Risk Factor Study Inclusion criteria 1. Aged 45 years old or above 2. Hong Kong citizens 3. Able to read Chinese 4. Able to self-complete a Chinese online dementia risk factor survey 5. Consent to participate in the risk factor study People with potential or confirmed cognitive impairment for Dementia Registry Inclusion criteria 1. Aged 45 years old or above 2. Hong Kong citizens 3. Potential or confirmed cognitive impairment (dementia is defined as AD8≧2) [58] 4. Able to take part in data collection 5. Consent to register in the Dementia Registry Caregivers of people with potential or confirmed cognitive impairment for Dementia Registry Inclusion criteria 1. Aged 18 years old or above 2. Caregivers of participants #2 3. Able to take part in data collection 4. Consent to participate in the Dementia Registry Participants for Risk Factor Study Inclusion criteria1. Aged 45 years old or above2. Hong Kong citizens3. Able to read Chinese4. Able to self-complete a Chinese online dementia risk factor survey5. Consent to participate in the risk factor studyPeople with potential or confirmed cognitive impairment for Dementia Registry Inclusion criteria1. Aged 45 years old or above2. Hong Kong citizens3. Potential or confirmed cognitive impairment (dementia is defined as AD8≧2) [58]4. Able to take part in data collection5. Consent to register in the Dementia RegistryCaregivers of people with potential or confirmed cognitive impairment for Dementia Registry Inclusion criteria1. Aged 18 years old or above2. Caregivers of participants #23. Able to take part in data collection4. Consent to participate in the Dementia Registry;
请登录查看Participants for Risk Factor Study Exclusion criteria 1. Not residing in Hong Kong 2. Unable to complete a Chinese online dementia risk factor survey 3. Not giving consent to research participation People with potential or confirmed cognitive impairment for Dementia Registry Exclusion criteria 1. Not residing in Hong Kong 2. Unable to take part in data collection 3. Not giving consent to research participation Caregivers of people with potential or confirmed cognitive impairment for Dementia Registry Exclusion criteria 1. Unable to take part in data collection 2. Not giving consent to research participation;
请登录查看Jockey Club Centre for Positive Ageing
000000
Jockey Club Centre for Positive Ageing的其他临床试验
Jockey Club Centre for Positive Ageing的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

